Articles
SOTAX Announces SOTAX Pharma Services — A Unique Contract Research Organization Based On Dissolution
July 24, 2007
SOTAX Corporation, (Horsham, PA, USA), SOTAX (Canada) Ltd., (Brampton, ON, Canada) SOTAX AG (Basel, Switzerland), and SOTAX China, (Shanghai, China) the worldwide market leader in USP Apparatus 4 Flow Through Dissolution introduces SOTAX Pharma Services. SPS is a unique Contract Research Organization based solely on one principle: Dissolution.
Dissolution is a characterization test used by the Pharmaceutical industry to formulate the release properties of active drug from a dosage form, develop quality control specifications for the manufacturing process and correlate with in vitro studies. With over 30 years of experience and innovation, SOTAX has manufactured the instruments needed by industry to develop a better understanding of dissolution. SPS Pharma Services brings to our product line another essential dissolution tool.
SPS is the only outsourcing company dedicated to dissolution testing for formulation and QA. Our highly experienced project team is supported world-wide by renowned Academic and Industrial experts.
Our Services include:
- System and Method Feasibility studies
- Method development
- Custom Instrument Development
- Method Transfer and Automation
- Based on Compendial USP and EU equipment
- APIs, Powder, Granules and Bead formulations
- Intrinsic and Apparent dissolution testing
- MR/ER Tablets and Capsules
- Poorly Soluble Compounds
- Medical Devices, Lenses and Drug Eluting Stents
- Elution Studies for Coated Drug Products
- Microspheres, Parenterals, Liposomes
- Creams, Ointments, Hydrogels
- Suspensions and Injectables
- Implants
- IVIVC
- And many more
Source: SOTAX Corporation



